- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05548335
Measurement of the Optic Nerve Sheath Diameter
August 7, 2023 updated by: Joshua Jacquet, Cleveland Clinic Akron General
Microconvex Probe Versus Linear Probe for Measurement of the Optic Nerve Sheath Diameter
This study is a prospective assessment of the accuracy of ocular ultrasound as a tool to measure the diameter of the optic nerve sheath and the eyeball transverse diameter in healthy adult patients presenting to the Emergency Department and have confirmatory imaging of the optic nerve as part of their clinical care.
Study Overview
Detailed Description
This will be a prospective evaluation of accuracy of microconvex and linear transducers for ultrasound measurements of the ONSD and the ETD.
Study population will be adult patients that present to Cleveland Clinic Akron General Emergency Department between July 1, 2022 and July 31 April 1, 2023.
Patients will be identified on the Emergency Medicine Department tracking board.
Patients, once identified as meeting inclusion criteria will be asked to participate in this study and full written consent will be required.
All participants will have identical procedures and there will be no groups.
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Joshua Jacquet, MD
- Phone Number: 330-344-6000
- Email: jacquej3@ccf.org
Study Contact Backup
- Name: Jessica Krizo, PhD
- Phone Number: 330-344-6316
- Email: krizoj@ccf.org
Study Locations
-
-
Ohio
-
Akron, Ohio, United States, 44307
- Recruiting
- Cleveland Clinic Akron General
-
Contact:
- Jessica Krizo
- Phone Number: 330-344-6316
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion criteria:
- 18 years of age and older, and;
- Present to Cleveland Clinic Akron General's ED (Main)
- Have CT head and/or ocular ordered as a part of clinical care that is read as normal or no acute disease (confirmatory imaging), and;
- Agree to and provide written consent for participation.
Exclusion criteria:
- Acute ocular pathology
- Abnormal brain and/or ocular CT
- History of increased intracranial pressure or optic nerve disease
- Not medically stable
- Pregnant or incarcerated
- Unable to consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Ocular Ultrasound
This arm includes all patients enrolled who will have an ocular ultrasound with two different probes for a total of four ultrasounds.
|
1. Patients presenting to the emergency department and have a normal head and/or ocular computed tomography scan will be considered for inclusion in this study.
Study staff will discuss the study with the patient and obtain consent.
At that point, operator will perform ocular ultrasound.
Procedure will start with either the linear or microconvex probe.
A single-use sterile gel packet will be used to apply gel to one closed eyelid.
The probe will be placed with minimal pressure on the eye.
A transverse measurement of the ONSD will be taken.
In this same view the maximal transverse diameter of the eyeball will also be measured.
Images of the eye with ONSD and ETD measurements will be captured.
Repeat until three measurements have been obtained resulting in an average ONSD and ETD for that eye.
Repeat for other eye.
Switch probe and repeat on both eyes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Primary objective is to determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the optic nerve sheath diameter compared to CT measurements.
Time Frame: through study duration, one year is anticipated.
|
The patient will be enrolled and be involved with the study for 15-20 minutes.
At this time the research procedures will be done.
|
through study duration, one year is anticipated.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To determine the level of intra- and inter-rater variability for ultrasound measurement of the optic nerve sheath diameter between the two transducer types.
Time Frame: through study duration, one year is anticipated.
|
The patient will be enrolled and be involved with the study for 15-20 minutes.
At this time the research procedures will be done.
|
through study duration, one year is anticipated.
|
To determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the eyeball transverse diameter compared to CT measurements.
Time Frame: through study duration, one year is anticipated.
|
The patient will be enrolled and be involved with the study for 15-20 minutes.
At this time the research procedures will be done.
|
through study duration, one year is anticipated.
|
To determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the ONSD/ETD compared to CT measurements.
Time Frame: through study duration, one year is anticipated.
|
The patient will be enrolled and be involved with the study for 15-20 minutes.
At this time the research procedures will be done.
|
through study duration, one year is anticipated.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Joshua Jacquet, MD, Cleveland Clinic Akron General
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2022
Primary Completion (Estimated)
December 30, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
July 1, 2022
First Submitted That Met QC Criteria
September 16, 2022
First Posted (Actual)
September 21, 2022
Study Record Updates
Last Update Posted (Actual)
August 8, 2023
Last Update Submitted That Met QC Criteria
August 7, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 21036
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Optic Nerve
-
University of Colorado, DenverTerminated
-
Shanghai Changzheng HospitalRenJi HospitalUnknown
-
Copenhagen University Hospital at HerlevRecruiting
-
University Hospital TuebingenCompleted
-
Buddhist Tzu Chi General HospitalRecruitingTraumatic Optic NeuropathyTaiwan
-
Beijing Tongren HospitalRecruiting
-
University of MagdeburgEBS Technologies GmbHCompletedOptic Nerve Diseases | Optic Nerve Injuries | Optic NeuropathiesGermany
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompletedOptic Radiation Neuropathy Following Radiotherapy ProcedureChina
-
University of MagdeburgEBS Technologies GmbHCompletedOptic Nerve Diseases | Optic Nerve Injuries | Optic NeuropathiesGermany
-
Iran University of Medical SciencesTehran University of Medical Sciences; Mashhad University of Medical SciencesCompletedTraumatic Optic NeuropathyIran, Islamic Republic of
Clinical Trials on Ocular Ultrasound
-
TriHealth Inc.TriHealth Hatton Research Institute; Jocelyn LaMar; Emily CraverCompletedHeart Arrest | Intracranial Pressure IncreaseUnited States
-
Oregon Health and Science UniversityCompletedHydrocephalusUnited States
-
michal rollUnknownPapilledema Associated With Increased Intracranial Pressure
-
Marmara UniversityWithdrawnPneumoperitoneum | Intraocular Pressure | Intracranial Pressure
-
Insel Gruppe AG, University Hospital BernStiftung OPOS; Fondation BertarelliRecruiting
-
Alcon ResearchCompletedDry Eye DiseaseAustralia
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
Brighton and Sussex University Hospitals NHS TrustCompletedAge Related Macular Degeneration | Cataract Senile | Epiretinal Membrane | Vitreomacular Traction | Macula HoleUnited Kingdom